NYSE

Sanofi sweetens Genzyme bid to $74/shr

French drug maker Sanofi-Aventis agreed to acquire U.S. biotechnology company Genzyme for $74.00 per share in cash or about $20.1 billion plus extra payments linked to experimental multiple sclerosis drug Lemtrada.
Traders work on the floor of the New York Stock Exchange

Stocks fall as retail sales data weighs

U.S. stocks slipped as retail sales raised doubts about the economic recovery. Energy and basic materials equities led the way downward, albeit in moderate trading volume.
More news
IBTimes Logo

World Market Overview 15/2/2011

U.S. stocks ended narrowly mixed as investors appeared to be underwhelmed by President Obama’s budget proposal, while unrest in the Middle East has spread to Iran and even Bahrain.
IBTimes Logo

Stocks yawn at Obama budget proposal

Stocks finished narrowly mixed as investors appeared to be underwhelmed by President Obama’s budget proposal, while unrest in the Middle East has spread to Iran and even Bahrain.
A worker cuts sugar cane for raw sugar and ethanol fuel production on the property of the Sao Martinho mill in Pradopolis, about 300 km (186 miles) northwest of Sao Paulo.

Ethanol best hope to replace oil: BP’s Dudley

Once the world’s crude oil reserves finally run out, the best hope for a replacement is ethanol derived from Brazilian sugar-cane, according to Bob Dudley, the chief executive of BP (NYSE: BP).

Stock rally on Mubarak resignation

Stocks rallied after Hosni Mubarak resigned as president of Egypt and the Obama administration announced plans to dissolve Fannie Mae and Freddie Mac
Nokia's new Chief Executive Stephen Elop (L) shakes hands with Nokia's Chairman of the Board Jorma Ollila during a news conference in Espoo Finland, September 10, 2010

Six Reasons Why Nokia Adopted WP7

It is official. Nokia will be adopting Microsoft's Windows Phone 7 as its new smartphone operating system (OS), a move that could be the beginning of a new era for the Finnish mobile giant.
The New York Stock Exchange

Deutsche Boerse-NYSE deal faces antitrust snags

Deutsche Boerse AG's planned takeover of NYSE Euronext faces intense scrutiny from German regulators and European antitrust authorities, potentially imperiling the blockbuster exchange tie-up.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.